Enterprise Europe Network

Method to obtain useful data for the screening and diagnosis of osteoporosis

Country of origin:
Country: 
SPAIN
Opportunity:
External Id: 
TOES20190424001
Published
24/04/2019
Last update
06/05/2019
Expiration date
06/05/2020

Keywords

Partner keyword: 
Pharmaceutical Products / Drugs
Physiotherapy, Orthopaedic Technology
Cellular and Molecular Biology
Biochemistry / Biophysics
Cellular and Molecular Biology
Other clinical medicine
Research and experimental development on social sciences and humanities
Other human health activities
EXPRESS YOUR INTEREST

Summary

Summary: 
A Spanish research group of the public health system has developed a method for screening, diagnosis, prognosis and/or monitoring osteoporosis. The method consists in a drug that allows obtaining useful data with more efficacy than current drugs. A license agreement or a technical cooperation agreement is sought.

Description

Description: 

Osteoporosis consists in a disorder in which the bones become increasingly porous, brittle, and subject to fracture, owing to loss of calcium and other mineral components, sometimes resulting in pain, decreased height, and skeletal deformities

Current drugs have a limited efficacy and an adverse effect.

Studies have shown the evidence of the relationship between intestinal hormones and bone health. The variation in food intake is associated with significant changes in bone markers reabsorption, being intestinal and pancreatic peptides the most important effectors of the acute response that occurs in bone metabolism regard to food intake.

The Spanish research group has developed a drug to obtain useful data for the screening, diagnosis, prognosis and/or monitoring osteoporosis.

The research group is looking for the following collaboration:
-License agreement: framework of authorizing the interested parties to use the method.
-Technical cooperation agreement: to collaborate with other research teams, companies or foundations.

Advantages & innovations

Cooperation plus value: 
-The elaboration of a drug for the prevention, relief, improvement and treatment of osteoporosis. -Non-invasive Clinical Trials have been carried out in 102 patients. -The methodology has already been used in other diseases like Diabetes mellitus. -In addition, it helps to lose weight, another advantage in osteoporosis disease.

Stage of development

Cooperation stage dev stage: 
Prototype available for demonstration

Partner sought

Cooperation area: 
The research group aims to formalize a technology transfer process with public or private entities interested in the implementation of the solution, through a license agreement. If there are some entities, such as R&D centres, technology centres or specialized companies, interested in collaborating and developing further aspects of the solution, a technical cooperation agreement could be envisaged. They already sell the plate in Spain and now they want to expand abroad.